SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-21-000068
Filing Date
2021-07-19
Accepted
2021-07-19 16:36:27
Documents
12
Period of Report
2021-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K supn-20210713.htm   iXBRL 8-K 35852
  Complete submission text file 0001356576-21-000068.txt   171983

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20210713.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20210713_lab.xml EX-101.LAB 24136
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20210713_pre.xml EX-101.PRE 12520
5 EXTRACTED XBRL INSTANCE DOCUMENT supn-20210713_htm.xml XML 10774
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 211098301
SIC: 2834 Pharmaceutical Preparations